Related Experiment Video

Updated: Jun 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Controlling the Mdm2-Mdmx-p53 Circuit

David L Waning1, Jason A Lehman, Christopher N Batuello

  • 1Herman B Wells Center for Pediatric Research, 980 West Walnut, Walther Hall R3-C548, Indianapolis, IN 46202, USA.

Pharmaceuticals (Basel, Switzerland)
|July 24, 2010
PubMed

Insights

The p53 tumor suppressor protein is crucial for genome integrity. Phosphorylation of p53, Mdm2, and Mdmx stabilizes p53, offering a therapeutic strategy, but kinase inhibitors require careful consideration.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The p53 tumor suppressor is vital for genomic stability, inducing cell cycle arrest or apoptosis.
  • Mdm2 and Mdmx inactivate p53 by inhibiting transcription and promoting degradation.
  • Post-translational modifications, particularly phosphorylation, stabilize and activate p53 under genotoxic stress.

Purpose of the Study:

  • To review key phosphorylation events of p53, Mdm2, and Mdmx in response to DNA damage.
  • To discuss the implications of these modifications for p53 stability and activity.
  • To evaluate therapeutic strategies targeting the Mdm2-Mdmx-p53 axis in cancer.

Main Methods:

  • Literature review focusing on phosphorylation events in the p53 pathway.
  • Analysis of studies investigating p53, Mdm2, and Mdmx regulation by DNA damage.
  • Examination of the therapeutic potential and risks of modulating the Mdm2-Mdmx-p53 axis.

Main Results:

  • Phosphorylation of p53, Mdm2, and Mdmx is critical for p53 stabilization and activation following genotoxic stress.
  • Modulating Mdm2 and Mdmx signaling presents a promising therapeutic strategy for reactivating wild-type p53 in tumors.
  • Targeting the Mdm2-Mdmx-p53 axis with kinase inhibitors requires careful consideration due to potential p53 inactivation.

Conclusions:

  • Phosphorylation plays a central role in the p53 response to DNA damage, influencing its stability and tumor suppressor function.
  • Targeting Mdm2 and Mdmx offers a viable therapeutic avenue for p53 reactivation in cancer treatment.
  • Development of kinase inhibitors must carefully balance therapeutic benefits against the risk of unintended p53 destabilization.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...